Mediclore

DEVICE4 trials

Sponsors

Daewoong Pharmaceutical Co. LTD., Yong Sang Song, Seoul National University Hospital, King Chulalongkorn Memorial Hospital

Conditions

AdhesionEpidural FibrosisFailed Back Surgery SyndromeGynecologic DiseaseLumbar Disc DiseasePatients With Thyroidecomy (Scheduled)Thyroidectomy

Phase 3

Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy

Daewoong Pharmaceutical Co. LTD.Patients With Thyroidecomy (Scheduled)

Start: 2016-08-31Target: 172Updated: 2016-09-21

Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)

Yong Sang SongGynecologic Disease

Start: 2016-12-31End: 2017-08-31Target: 192Updated: 2017-01-05

Phase 4

Anti-adhesive Effect and Safety of Thermo-sensitive Adhesion Barrier (MEDICLORE)

CompletedNCT03293186

Seoul National University HospitalAdhesion, Thyroidectomy

Start: 2017-07-01End: 2020-12-31Updated: 2021-03-17

The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study

King Chulalongkorn Memorial HospitalEpidural Fibrosis, Failed Back Surgery Syndrome, Lumbar Disc Disease

Start: 2023-10-31End: 2024-06-30Target: 78Updated: 2023-09-14